Nivolumab Biosimilar - Research Grade
Product Specifications
Background
Nivolumab biosimilar is a human monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. Nivolumab is an IgG4 kappa immunoglobulin that has a calculated molecular mass of 146 kDa. It is expressed in a recombinant Chinese Hamster Ovary (CHO) cell line.
Specifications
Detects human PD-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Nivolumab.
Product Name Alternative
Programmed cell death protein 1, Pdcd1, CD279
UniProt
Q15116
Host
Humanized
Species Reactivity
Human
Target
PD-1
Isotype
IgG4 kappa
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
1.0 - 5.0 mg/mL
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE and HPLC
Buffer
ICH3001-100mL ICH3002-100mL ICH3003-100mL
Shipping Conditions
Blue ice
Storage Conditions
Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Formulation
Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
Isotype Control
https://ichor.bio/product/bulk-human-igg4-isotype-control-ib4-ich2257/
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471906-100 1x 100 µL
Chromogranin A / CHGA (Neuroendocrine Marker) (rCHGA/413), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
PKSH033857-01 20 µg
Recombinant Human BCMA/TNFRSF17 (C-Fc-Avi) Biotinylated
Sign In for Pricing
View Details